fluoxetine has been researched along with phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almada, RC; Audi, EA; Coimbra, NC; Graeff, FG; Maraschin, JC; Roncon, CM; Zangrossi, H | 1 |
1 other study(ies) available for fluoxetine and phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide
| Article | Year |
|---|---|
Pharmacological evidence for the mediation of the panicolytic effect of fluoxetine by dorsal periaqueductal gray matter μ-opioid receptors.
Topics: Analgesics, Opioid; Animals; Avoidance Learning; Catheters, Indwelling; Dose-Response Relationship, Drug; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Escape Reaction; Fluoxetine; Male; Microinjections; Narcotic Antagonists; Neuropsychological Tests; Periaqueductal Gray; Psychotropic Drugs; Random Allocation; Rats, Wistar; Receptors, Opioid, mu; Somatostatin | 2015 |